HYALURONIDASE Side Effects

6382898-3 | Cellulitis Orbital, Parophthalmia
on Sep 25, 2009 Male patient from UNITED STATES , 81 years of age, weighting 180.0 lb, was diagnosed with cataract operation and was treated with Hyaluronidase (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis orbital, parophthalmia. Hyaluronidase dosage: 1cc 1 Dose Ophthalmic.

6382897-1 | Inflammation, Periorbital Cellulitis, Periorbital Disorder, Post Procedural Complication, Visual Acuity Reduced
Patient was taking Hyaluronidase (View Usage). Patient had the following side effects: inflammation, periorbital cellulitis, periorbital disorder, post procedural complication, visual acuity reduced on Sep 25, 2009 from UNITED STATES Additional patient health information: Male patient , 87 years of age, weighting 165.0 lb, was diagnosed with conjunctival operation and. Hyaluronidase dosage: 1cc 1 Dose Ophthalmic.

6379770-1 | Cellulitis Orbital, Parophthalmia
Adverse event was reported on Sep 24, 2009 by a Female patient taking Hyaluronidase (View Usage) (Dosage: 1cc 1 Dose Ophthalmic) was diagnosed with cataract operation, corneal transplant and. Location: UNITED STATES , 65 years of age, weighting 170.0 lb, After Hyaluronidase was administered, patient had the following side effects: cellulitis orbital, parophthalmia.

6379769-5 | Cellulitis Orbital, Erythema, Pain, Parophthalmia, Swelling, Visual Acuity Reduced
on Sep 24, 2009 Male patient from UNITED STATES , 65 years of age, weighting 170.0 lb, was diagnosed with pterygium and was treated with Hyaluronidase (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis orbital, erythema, pain (What is pain?), parophthalmia, swelling, visual acuity reduced. Hyaluronidase dosage: 1cc 1 Dose Retrobulbar, 1 Time Use.


6370224-5 | Cellulitis Orbital, Inflammation, Periorbital Disorder, Visual Acuity Reduced, Vitreous Disorder
on Sep 22, 2009 Male patient from UNITED STATES , 82 years of age, weighting 165.0 lb, was diagnosed with retinal operation and was treated with Hyaluronidase (View Usage). Patient had the following side effects: cellulitis orbital, inflammation, periorbital disorder, visual acuity reduced, vitreous disorder. Hyaluronidase dosage: 1cc 1 Dose Retrobulbar. During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), MARCAINE (View Marcaine Review and Marcaine Label ).

6370210-5 | Cellulitis Orbital, Eye Pain, Eye Swelling, Ocular Hyperaemia, Parophthalmia, Post Procedural Complication, Visual Acuity Reduced
Patient was taking Hyaluronidase (View Usage). After Hyaluronidase was administered, patient had the following side effects: cellulitis orbital, eye pain, eye swelling, ocular hyperaemia, parophthalmia, post procedural complication, visual acuity reduced on Sep 22, 2009 from UNITED STATES Additional patient health information: Female patient , 91 years of age, weighting 130.0 lb, was diagnosed with open angle glaucoma and. Hyaluronidase dosage: 1cc 1 Dose Ophthalmic. During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

6370208-7 | Cellulitis Orbital, Inflammation, Periorbital Disorder, Visual Acuity Reduced
Adverse event was reported on Sep 22, 2009 by a Male patient taking Hyaluronidase (View Usage) (Dosage: 1cc 1 Dose Retrobulbar) was diagnosed with pterygium operation and. Location: UNITED STATES , 50 years of age, weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: cellulitis orbital, inflammation, periorbital disorder, visual acuity reduced. During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

5589304-7 | Catheter Site Haematoma, Impaired Healing, Infusion Site Erythema, Infusion Site Swelling
on Jan 09, 2008 Male patient from UNITED STATES , weighting 3.75 lb, was diagnosed with infusion site extravasation and was treated with Hyaluronidase (View Usage). Patient had the following side effects: catheter site haematoma, impaired healing, infusion site erythema, infusion site swelling. Hyaluronidase dosage: 1 Ml = 150 Units X 1 Sq Per Neofax 2006.

5271863-5 | Cellulitis Orbital, Post Procedural Complication
on Feb 28, 2007 Male patient from AUSTRALIA , 66 years of age, was treated with Hyaluronidase (View Usage). After Hyaluronidase was administered, patient had the following side effects: cellulitis orbital, post procedural complication. Hyaluronidase dosage: 750iu Injection 055. During the same period patient was treated with 1% ROPIVACAINE HYDROCHLORIDE (View 1% Ropivacaine Hydrochloride Review and 1% Ropivacaine Hydrochloride Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.